RxDoctor Payments Data

Nitika Ghattaura

Rheumatology · Maple Grove, MNNPI 1356748495

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 25th percentile of 121 rheumatology providers in Minnesota.

See all rheumatology providers in Minnesota

Medicare billing

Part B allowed, 2024
$516,318
Medicare patients
208
Services billed
37,544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab66$460,420
Enbrel SureclickEtanercept31$221,505
Humira PenAdalimumab12$82,196
EnbrelEtanercept13$45,561
Hydroxychloroquine Sulfate165$6,176
MethotrexateMethotrexate Sodium169$5,837
Mycophenolate Mofetil11$1,755
Prednisone180$1,754
Colchicine11$1,144
Pilocarpine Hcl11$1,068
Sulfasalazine12$655
Allopurinol21$360
Meloxicam11$266
Folic Acid13$135
Alendronate Sodium13$87

Paid to pharmacies, not to this prescriber.

Other rheumatology in Maple Grove

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →